Olugbenga Ogedegbe

Professor of Social and Behavioral Sciences

Professor for the Department of Population Health at NYU Grossman School of Medicine

Professional overview

Gbenga Ogedegbe, a physician, is Professor of Population Health & Medicine, Chief Division of Health & Behavior and Director Center for Healthful Behavior Change in the Department of Population Health at the School of Medicine. Gbenga is a leading expert on health disparities research; his work focuses on the implementation of evidence-based interventions for cardiovascular risk reduction in minority populations. He is Principal Investigator on numerous NIH projects, and has expanded his work globally to Sub-Saharan Africa where he is funded by the NIH to strengthen research capacity and reduce the burden of noncommunicable diseases. He has co-authored over 250 publications and his work has been recognized by receipt of several research and mentoring awards including the prestigious John M. Eisenberg Excellence in Mentorship Award from the Agency for Healthcare Research and Quality, and the Daniel Savage Science Award. He has served on numerous scientific panels including the NIH, CDC, World Health Organization, and the European Union Research Council. Prior to joining NYU, he was faculty at Cornell Weill Medical School and Columbia University College of Physicians and Surgeons. 

Education

MPH from Columbia University, 1999

Residency, Montefiore Medical Center, Internal Medicine, 1998

MD from Donetsk University, 1988

Areas of research and study

Access to Healthcare

Global Health

Health of Marginalized Population

Implementation and Impact of Public Health Regulations

Implementation science

Stroke and Cardiovascular Disease

Publications

Publications

Functional capacity is a better predictor of coronary heart disease than depression or abnormal sleep duration in Black and White Americans

Lay representations of chronic diseases in Ghana: implications for primary prevention.

Overcoming barriers to hypertension control in African Americans

Patient Factors, But Not Provider and Health Care System Factors, Predict Medication Adherence in Hypertensive Black Men

Race differences in the physical and psychological impact of hypertension labeling

Race/ethnicity, sleep duration, and diabetes mellitus: Analysis of the national health interview survey

Relationship between post-traumatic stress disorder and diabetes among 105 180 asylum seekers in the Netherlands

Resistant hypertension

Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-Americans

Stroke in Ashanti region of Ghana.

The effect of patient-provider communication on medication adherence in hypertensive black patients: Does race concordance matter?

A practice-based trial of blood pressure control in African Americans (TLC-Clinic): study protocol for a randomized controlled trial

Cardiovascular disease prevention in Ghana: Feasibility of a faith-based organizational approach

Correlations between different measures of clinic, home, and ambulatory blood pressure in hypertensive patients

HIV and General Cardiovascular Risk

Hypertension in the high-cardiovascular-risk populations

McFarlane, S. I., Jean-Louis, G., Zizi, F., Whaley-Connell, A. T., Ogedegbe, O., Makaryus, A. N., & Maraj, I. (n.d.).

Publication year

2011

Journal title

International Journal of Hypertension

Volume

2011

10.4061/2011/746369

Management of hypertension among patients with coronary heart disease

Management of hypertension in high-risk ethnic minority with heart failure

Meta-analysis: Impact of drug class on adherence to antihypertensives

Primary care equals secondary prevention in ischemic heart disease

Racial/ethnic residential segregation and self-reported hypertension among US-and Foreign-Born Blacks in New York City

Racism and hypertension: A review of the empirical evidence and implications for clinical practice

Resistant hypertension and obstructive sleep apnea in the primary-care setting

Resistant hypertension and sleep apnea: Pathophysiologic insights and strategic management

Williams, S. K., Ravenell, J., Jean-Louis, G., Zizi, F., Underberg, J. A., McFarlane, S. I., & Ogedegbe, G. (n.d.).

Publication year

2011

Journal title

Current Diabetes Reports

Volume

11

Issue

1

Page(s)

64-69

10.1007/s11892-010-0161-z

Abstract

Abstract

Resistant hypertension is common among adults with hypertension affecting up to 30% of patients. The treatment of resistant hypertension is important because suboptimal blood pressure control is the leading preventable cause of death worldwide. A frequent comorbid condition in patients with resistant hypertension is obstructive sleep apnea. The pathophysiology of sleep apnea-associated hypertension is characterized by sustained adrenergic activation and volume retention often posing treatment challenges in patients with resistant hypertension. This review will address some of the epidemiologic data associating apnea with the pathogenesis of resistant hypertension. Diagnosis and management of apnea and its associated hypertension will also be considered.

Socioeconomic position is positively associated with blood pressure dipping among African-American adults: The Jackson heart study